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Abstract
The significance of hepatitis E virus (HEV) as an important public health problem
is rising. Until a decade ago, cases of HEV infection in Eur-ope were mainly
confined to returning travelers, but nowadays, hepatitis E represents an emerging
zoonotic infection in many European countries. The aim of this manuscript is to
perform a systematic review of the published literature on hepatitis E distribution
in humans, animals and environmental samples ("One Health" concept) in the
South-Eastern European countries. Comparison of the available data showed that
the anti-HEV seroprevalence in the South-Eastern Europe varies greatly,
depending on the population studied, geographical area and methods used. The
IgG seroprevalence rates in different population groups were found to be 1.1%-
24.5% in Croatia, up to 20.9% in Bulgaria, 5.9-%17.1% in Romania, 15% in Serbia,
up to 9.7% in Greece and 2%-9.7% in Albania. Among possible risk factors, older
age was the most significant predictor for HEV seropositivity in most studies.
Higher seroprevalence rates were found in animals. HEV IgG antibodies in
domestic pigs were detected in 20%-54.5%, 29.2%-50%, 38.94%-50% and 31.1%-
91.7% in Serbia, Bulgaria, Romania and Croatia, respectively. In wild boars
seroprevalence rates were up to 10.3%, 30.3% and 31.1% in Romania, Slovenia
and Croatia, respectively. A high HEV RNA prevalence in wild boars in some
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countries (Croatia and Romania) indicated that wild boars may have a key role in
the HEV epidemiology. There are very few data on HEV prevalence in
environmental samples. HEV RNA was detected in 3.3% and 16.7% surface
waters in Slovenia and Serbia, respectively. There is no evidence of HEV RNA in
sewage systems in this region. The available data on genetic characterization
show that human, animal and environmental HEV strains mainly belong to the
genotype 3.
Key words: Hepatitis E virus; "One-Health"; Humans; Animals; Environment; South-East
Europe
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Core tip: In South-East Europe, the hepatitis E virus (HEV) prevalence as in other parts
of Europe varies greatly, depending on the studied population, geographical area and
methods used. Seroprevalence rates were found to be 0%-36% in humans and 10.3%-
54.5% in animals. Human studies showed sporadic detection of HEV RNA in patients
with acute hepatitis and in transplant population. HEV RNA was detected in up to 31.6%
pigs and 16.7% environmental samples. Studies on phylogenetic characterization in
human, animal and environmental samples showed that HEV strains from the south-
eastern European countries mainly belong to the genotype 3.
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INTRODUCTION
Hepatitis E represents an important public health problem in many parts of the world.
The World Health Organization estimates that 20 million hepatitis E virus (HEV)
infections occur worldwide leading to an estimated 3.3 million symptomatic cases and
44000 deaths related to hepatitis E. Until a decade ago, cases of HEV infection in
Europe were mainly confined to travelers returning from endemic areas, whereas
nowadays, hepatitis E is endemic in many European countries. It is estimated that 5%-
15% of  all  acute hepatitis  infections of  unknown origin in Europe are caused by
HEV[1]. The seroprevalence ranges from 0.6% to 52.5%, depending on the population
group tested and geographical region. In addition to differences in seroprevalence
rates between countries, there are also differences in HEV seropositivity within the
same  country [2].  Changes  in  HEV  epidemiology  could  be  explained  by  the
confirmation of zoonotic nature of the disease. To date, three zoonotic HEV genotypes
have been confirmed to infect humans. In addition to well-known HEV-3 and HEV-4
genotypes,  a  new  genotype  HEV-7  has  also  been  recently  described  to  infect
humans[3,4].  Domestic  pigs  and wild  boars  represent  the  most  important  animal
reservoirs for HEV-3 and HEV-4 worldwide with usually high seroprevalence rates
ranging between 23%-100%[5]. However, zoonotic transmission of HEV has also been
reported from some other animal reservoirs such as rabbits, deer and camels[3,6-8]. In
addition, HEV must be considered as a food-borne pathogen as well, since food-borne
cases of hepatitis E in humans are increasingly reported. Food-borne HEV-3 and
HEV-4 infections due to consumption of undercooked meat and meat products from
infected animal reservoirs have been repeatedly described[4,6,9-11]. Furthermore, HEV-3
has also been found in mollusks and human consumption of contaminated shellfish
has been implicated as the cause of sporadic cases of acute hepatitis E[12,13]. Other types
of food such as berry fruit have rarely been suspected to act as vehicles for HEV
transmission after environmental contamination with animal feces[14,15].
In this  manuscript,  a  bibliographic review of  the literature on hepatitis  E was
performed with the aim of gathering the latest data regarding the prevalence, risk
factors  and  HEV  genotype  distribution  in  the  South-East  Europe  in  the  multi-
disciplinary "One Health" concept (Tables 1-3).
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Table 1  Prevalence of hepatitis E in different population groups
Country Population Sample size Method anti-HEV
HEV RNA
(%)/genotype
(subtype)
Ref.
Albania Refugees in Greece
(pregnant women)
500 EIA 2%1 NT Malamitsi-Puchner
et al[16]
Refugees in Greece
(adult population)
350 EIA/IB 4.85%1 NT Dalekos et al[17]
General population ND ND IgG 9.7% NT Adhami et al[18]
Thalassemic
children
ND ND IgG 0% NT
Patients with
chronic liver disease
109 EIA 36.6%1 NT Kondili et al[19]
Patients with no
apparent liver
disease
190 EIA 12.1%1 NT
Bulgaria Patients with
symptoms of acute
hepatitis
806 EIA IgM/IgG 2.48% NT Baymakova et al[23]
Hospitalized
patients with clinical
symptoms of
hepatitis and
outpatients with
laboratory data of
liver dysfunction
325 EIA IgM 13.2% NT Stoykova et al25]
IgG 20.9% NT
Patients with acute
hepatitis E (IgM
positive)
105 RT-PCR NT G3 98% (3e 62%; 3f
24%; 3c 13%); G1 2%
Bruni et al[26]
Patients conducting
ambulatory
examination due to
various reasons
741 EIA IgM/IgG 1.48% Teoharov et al[27]
IgG 9.04%
Croatia Patients with clinical
symptoms of
hepatitis negative
for
HAV/HBV/HCV
504 EIA/IB/RT-PCR IgM/IgG 10.7% IgM positive 35.7% Đaković Rode et
al[31]
HIV-infected
patients
88 EIA/IB IgG 1.1% NT
Liver transplant
recipients
242 EIA IgG 24.5% NT Mrzljak et al[32]
Alcohol abusers 56 EIA/IB IgG 8.9% NT Vilibic-Cavlek et
al[33]
Patients with PTSD 35 EIA/IB IgG 8.1% NT
Injecting drug users 49 EIA/IB IgG 6.1% NT
Persons with risk
sexual behaviour
37 EIA/IB IgG 0% NT
Forest workers 37 EIA/IB IgG 8.1% NT Jeličić et al[34]
Healthcare workers 50 EIA/IB IgG 2.0% NT Jeličić et al[34]
Pregnant women 68 EIA/IB IgG 2.9% NT Jeličić et al[35]
Hunters 25 EIA/IB IgG 4.0% NT Jeličić et al[35]
General population 87 EIA/IB IgG 3.4% NT Jeličić et al[34]
Blood donors 1036 EIA/IB EIA IgM 1.7% IgG 20.3% NT Miletic Lovric et al[36]
Greece Transplant patients 76 RT-PCR NT 1 positive/1.3% G3 Sinakos et al[45]
Transfusion
dependent
thalassaemia
96 EIA IgG 0% 0% Klonizakis et al[44]
Blood donors 1 200 EIA IgG 2.9% NT Zervou et al[49]
HIV patients 243 EIA IgG 7.3% NT Politou et al[48]
Blood donors (South
Greece)
265 EIA IgG 9.43 NT Pittaras et al[47]
Patients after open-
heart surgery
204 EIA IgG 5.4% NT Zervou et al[43]
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Patients on
haemodialysis
351 EIA IgG 4.8% NT Stefanidis et al[46]
Non-A,-B hepatitis
patients
198 EIA/RT-PCR IgG 7.6% IgM 1% 1 positive Psichogiou et al[42]
Healthy controls 316 EIA/RT-PCR IgM 0%/IgG 2.2% NT
Epirus region Healthy blood
donors
2636 EIA/IB IgG 0.23% NT Dalekos et al[17]
Refugees from
southern Albania
350 EIA/IB IgG 4.85% NT
Children 165 EIA/IB IgG 0% NT
Injecting drug users 65 EIA/IB IgG 0% NT
Multiply transfused
patients
62 EIA/IB IgG 0% NT
Patients with
chronic viral
hepatitis
75 EIA/IB IgG 5.30% NT
Chronic
haemodialysis
patients
149 EIA/IB IgG 1.34% NT
Agrinion area Healthy blood
donors
380 EIA/IB IgG 0.53% NT
Chronic
hemodialysis
patients
62 EIA/IB IgG 9.7% NT
Kosovo Kosovar refugees 104 EIA/RT-PCR IgM 7.7% 0% Rey et al[56]
Montenegro Patients with acute
viral hepatitis
400 EIA IgM 6% NT Terzić et al[57]
Romania Patients with
hepatitis B or C
25 EIA IgG 12% NT Anita et al[59]
Students 40 EIA IgG 12.5% NT Voiculescu et al[60]
Doctors and nurses 93 EIA IgG 13.98% NT Voiculescu et al[60]
Persons undergoing
routine
hematological tests
148 EIA IgG 14.86% NT Anita et al[61]
General population 67 EIA IgG 5.9% NT Savuta G et al[62]
Serbia Blood donors 200 EIA RT-PCR IgG 15% 0% Petrović et al[66]
Slovenia Acute/recent
hepatitis E (IgM
antibodies)
10 RT-PCR NT 3/10 (G3e and G1) Steyer et al[74]
1Total anti-hepatitis E virus antibodies. HEV: Hepatitis E virus; EIA: Enzyme immunoassay; IB: Immunoblot; RT-PCR: Reverse-transcriptase polymerase
chain reaction; NT: Not tested; ND: No data.
Search strategy and selection criteria
A literature search was conducted in the following electronic databases: PubMed,
Web of Science, Medline and Scopus along with hand-searching references of key
articles and a ResearchGate and Google search with no limitations placed on year of
publication and language restriction. The search included articles in peer-reviewed
journals and grey literature. Books, dissertations, review articles and unpublished
reports were excluded. In addition, non-relevant studies by the review of the abstracts
were  also  excluded.  Keywords  searched were:  Hepatitis  E  virus,  epidemiology,
human,  animals,  pigs,  wild  boars,  environment,  waste  water,  vegetables,
seroprevalence,  risk factors,  HEV RNA, genotype.  Once a  comprehensive list  of
abstracts has been retrieved and reviewed, any studies appearing to meet inclusion
criteria were reviewed in full.
Out of 11 south-eastern European countries, data for Albania, Bulgaria, Croatia,
Greece,  Kosovo,  Montenegro,  Romania,  Serbia  and  Slovenia  are  available  and
presented in this review (Figure 1). So far, there have been no data published on HEV
for Bosnia and Herzegovina and the Republic of North Macedonia.
ALBANIA
There are few studies on hepatitis E in Albania published in 1990s and 2000s. In the
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Table 2  Prevalence of hepatitis E in different animal species
Coun-
try Population Sample size Method anti-HEV
HEV RNA (%)/genotype
(subtype) Ref.
Bulgaria Piglets 44 EIA IgG 50% NT Pishmisheva et al[28]
Fattening pigs 41 EIA IgG 29.2% NT
Croatia Domestic pigs 848 RT-PCR NT 24.5% (G3) Prpić et al[40]
Wild boars 536 RT-PCR NT 12.3% (G3)
Molluscs (mussels, oysters) 538 RT-PCR NA 0%
Cattle 32 RT-PCR NT 0%
Red fox 50 RT-PCR NT 0%
Deer 320 RT-PCR NT 0%
Muflons 12 RT-PCR NT 0%
Ferrets 8 RT-PCR NT 0%
Martens 10 RT-PCR NT 0%
Pigs (serum samples) 60 EIA/RT-PCR IgG 91.7% 13.3% 8.1% Lipej et al[39]
Pigs (bile samples) 60 RT-PCR NA 8.1%
Pigs, domestic 1424 EIA/RT-PCR IgG 32.94% 0% Jemeršić et al[41]
Wild boars 1000 EIA/RT-PCR IgG 31.10% 11.33%
Greece Mussels 51 RT-PCR NT 0% Diez-Valcarce et al55]
Black rats/Norway rats 20 RT-PCR NT 10% Ryll et al[50]
Roma-
nia
Farm pigs 50 EIA/IB IgG 50% NT Savuta et al[62]
Backyard pigs 95 EIA/IB IgG 38.94%
Backyard pigs 112 EIA IgG 49.27% NT Savuta et al[58]
Pigs (2-4 mo) stool samples 19 RT-PCR NT 31.58% (G3) Anita et al[61]
Wild boars 52 EIA 9.61%1 NT Porea et al[63]
Wild boars 68 EIA IgG 10.29% NT Porea et al[63]
Wild boars 50 RT-PCR NT 18% (G3) Porea et al[65]
Serbia Farm pigs (pooled stool samples) 30 RT-PCR NT 30% Petrovic et al[67]
Farm pigs (polled tissue samples) 20 RT-PCR NT 45%
Backyard pigs (pooled tissue
samples)
15 RT-PCR NT 0%
Wild boars (pooled stool samples) 10 RT-PCR NT 0%
Backyard pigs 315 EIA IgG 34.6% NT Lupulovic et al[68]
Pigs (liver samples) 50 NT NT 26% Savic et al[69]
Fattening pigs 95 NT NT 7.37% Petrović et al[71]
Piglets (8 wk) 50 NT NT 64%
Pigs (blood samples) 55 EIA IgG 54.54% NT Lupulovic et al[70]
Pigs (meat juice samples) 55 EIA IgG 20% NT
Slovenia Black rats/Norway rats 17/1 RT-PCR NT 0% Ryll et al[50]
Domestic pigs 85 RT-PCR NT 20.3% Steyer et al[74]
Suckling pigs (0-3 wk) 38 RT-PCR NT 5.3%
Weanling pigs (3-10 wk) 21 RT-PCR NT 28.6%
Fattening pigs (> 10 wk) 26 RT-PCR NT 26.9%
Wild boars 288 EIA/RT-PCR 30.21%1 0.35% Žele et al[75]
Pigs (stool samples) 811 RT-PCR NT 5.4% Raspor Lainšček et al[76]
Pigs (bile samples) 811 RT-PCR NT 4.9%
Pigs (liver samples) 811 RT-PCR NT 5.3% (G3a, 3b, 3c, 3e)
1Total anti-hepatitis E virus antibodies. HEV: Hepatitis E virus; EIA: Enzyme immunoassay; IB: Immunoblot; RT-PCR: Reverse-transcriptase polymerase
chain reaction; NT: Not tested; NA: Not applicable.
studies conducted among Albanian refugees in Greece, the anti-HEV prevalence was
2% among pregnant women[16]  and 4.85% in the adult  population from southern
Albania[17]. In 2000s, acute HEV in Albania made up 2.4% of all acute viral hepatitis
cases. HEV infections occurred more frequently in women (female to male ratio 2:1),
WJG https://www.wjgnet.com July 7, 2019 Volume 25 Issue 25
Mrzljak A et al. Hepatitis E in South-East Europe
3172
Table 3  Prevalence of hepatitis E virus RNA in different environmental samples
Country Sample Sample size HEV RNA (%)/ genotype (subtype) Ref.
Greece Vegetable leafy greens Pooled samples 4.76%1 3.2%1 Kokkinos et al[51]
Sewage 48 0% Kokkinos et al[54]
Sewage 5 0% Clemente-Casares et al[53]
Serbia Vegetable leafy greens Pooled samples 4.76%1 3.2%1 Kokkinos et al[51]
Berry fruits Pooled samples 2.5%1 Maunula et al[15]
Surface waters 60 16.67% Lazić et al[73]
Urban sewage 6 0%
Slovenia Waste water treatment plant 12 0% Steyer et al[77]
Swabs from the different site on the slaughter line 62 3.2% (G3) Raspor Lainšček et al[76]
Minced meat 22 0%
Bratwurst 30 0%
Surface water 60 3.3% (G3) Steyer et al[74]
1Pooled samples. HEV: Hepatitis E virus; EIA: Enzyme immunoassay; IB: Immunoblot; NT: Not tested.
as well as in adults over 35 years (73.3%). In the general population, the prevalence of
anti-HEV antibodies was 9.7% and increased progressively with age, from 1.2% in
children less than 9 years to 17.7% in persons older than 60 years.  There was no
difference in the prevalence between the general population and patients with chronic
liver disease (10.5%). The prevalence of anti-HEV antibodies in pregnant women was
lower than in the general population (1.1%). No positive cases were found among
children with thalassemia receiving multiple transfusions[18]. In contrast, in the other
Albanian case-control  study,  HEV antibodies were found in 36.6% patients with
chronic liver disease compared to 12.1% in patients with no apparent liver disease. In
the univariate analysis, anti-HEV prevalence was found to be associated with the age
(> 50 years), lower education status (≤ 8 years of formal education) and positivity for
hepatitis B surface antigen (HBsAg), while no association was observed in people who
lived in villages and/or those who were occupationally involved with handling
animals. In the multivariate analysis, significant associations remained for age and
HBsAg positivity[19].
Since there are no recent data on HEV infection in Albania, the burden of diseases
caused  by  HEV  is  not  known.  Moreover,  no  data  on  the  role  of  animals  in  the
epidemiology of HEV infections in Albania is currently available. Therefore, more
research should be done to evaluate a local HEV epidemiology in Albania.
BULGARIA
In Bulgaria, the first human cases of hepatitis E were reported in 1995[20].  Several
studies  reported  cases  and  hospitalized  patients  with  acute  hepatitis  E[21,22].  A
retrospective study of acute viral hepatitis performed in Sofia (2004-2012) found anti-
HEV IgM/IgG antibodies in 2.48% patients[23]. HEV infection more frequently affected
males (61%-69%), with the highest incidence in persons over 50 years of age[23,24].
Another study in the North-Eastern Bulgaria (2012-2016) analyzed the prevalence of
HEV infection in hospitalized patients with clinical symptoms of acute hepatitis and
outpatients  with  laboratory  data  of  liver  dysfunction.  Acute  infection  was
documented in 13.2% patients,  while 20.9% patients showed only IgG antibodies
indicating past HEV infection[25]. A study conducted from 2013 to 2015 analyzed HEV
genotypes in patients with acute hepatitis E. Phylogenetic analysis showed HEV-3 in
98% and HEV-1 in 2% of cases. Subtyping of HEV-3 sequences showed 3e (62%), 3f
(24%) and 3c (13%) subtypes. There were differences in the geographical distribution
of genotypes. Subtypes 3f and 3c were scattered throughout the country, while 3e
subtype  was  restricted  to  the  South-West  area[26].  A  seroepidemiological  study
conducted in the general Bulgarian population from Plovdiv region during 2012-2013
found anti-HEV IgG seroprevalence of 9.04%, while 1.48% participants showed both
IgM and IgG antibodies. Seropositivity did not differ significantly between males
(9.87%) and females (8.47%), but increased with the age from 3.53% in the age group
1-9 years to 19.23% in the group over 60 years[27].
In 2016, serum samples from clinically healthy pigs from five industrial farms in
two districts in South Bulgaria were collected and tested for the presence of anti-HEV
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Figure 1
Figure 1  Data on hepatitis E prevalence in South-East Europe in humans, animals and environmental
samples ("One health" concept).
antibodies.  The  overall  HEV seroprevalence  was  40.0% with  50.0% seropositive
piglets and 29.2% fattening pigs. Seropositivity differed significantly among regions
from 0% (Peshtera) to 100% (Nova Zagora)[28]. In a recently published study, genetic
diversity and the phylogenetic relationships among different strains of human HEV
genotype 3 were analyzed to estimate the date of origin and the demographic history
of  HEV epidemic in Bulgaria.  The root  of  the Bayesian tree showed at  least  two
different epidemic entrances for HEV genotype 3e strains[29].
Seroprevalence data and the high prevalence of clinical cases registered indicate
that HEV infection in Bulgaria is endemic. Phylogenetic analysis showed that human
HEV isolates in 98% of cases belonged to HEV 3 genotype.
CROATIA
In Croatia, the first autochthonous human case of hepatitis E was reported in 2012[30].
A study conducted from 2011 to 2013 in patients with clinical symptoms of hepatitis
and elevated liver enzymes who tested negative for hepatitis A-C, detected HEV
IgM/IgG antibodies in 10.7% patients. Among IgM positive patients, 35.7% were
positive for HEV RNA[31].
Several  studies  analyzed  the  seroprevalence  of  HEV  infection  in  different
population groups in  Croatia.  HEV IgG antibodies  were detected in  24.5% liver
transplant  recipients[32],  8.9% alcohol  abusers[33],  8.6% patients  with  war-related
posttraumatic stress disorder[33], 8.1% forest workers[34], 6.1% injecting drug users[33],
4.0% hunters[35], 3.4% general population[34], 2.9% pregnant women[35], 2.0% healthcare
workers[34]  and  1.1%  HIV-infected  patients[31].  No  person  with  high-risk  sexual
behavior was HEV seropositive[33]. One study conducted among blood donors in 2016
showed a high IgG seroprevalence rate of 20.3% with 1.7% IgM positive. None of IgM
positive  samples  was  positive  for  HEV  RNA[36].  HEV  IgG  positivity  increased
significantly  with  the  age[33,37].  In  addition,  seroprevalence  rates  were  higher  in
residents of suburban and rural areas compared with residents of urban areas, sub-
jects living in families with more household members, persons who use wells as a
source of drinking water[33] and those who use a sewage system connected to a septic
tank[37].  Gender,  marital  status,  educational  level,  history  of  blood transfusions,
surgical  procedures,  tattooing  and  traveling  were  not  associated  with  HEV
seropositivity[33]. In 2018, the first documented case of HEV induced acute-on-chronic
liver  failure  was  reported  with  severe  clinical  course  considered  for  liver  tran-
splantation. The patient was treated with ribavirin and subsequently recovered[38].
Several studies addressed the HEV distribution in domestic animals and wildlife in
Croatia[39,40]. During 2009-2010, a comprehensive survey was carried out based on HEV
RNA detection in blood, spleen and liver samples originating from different domestic
and wild animals from all Croatian counties. Furthermore, digestive gland samples
from molluscs  were  also  analyzed.  A  high  HEV RNA prevalence  was  found in
domestic pigs (24.5%) and wild boars (12.3%), whereas cattle, molluscs, ruminant and
carnivore wildlife samples tested negative. Molecular characterization confirmed the
phylogenetic clustering of the obtained sequences into HEV genotype 3[40]. In 2012, the
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epidemiology of naturally occurring hepatitis E was investigated in swine herds from
three  large  pig  farms  in  continental  Croatia.  Nearly  all  animals  (91.7%)  tested
seropositive for HEV. In addition, active infection was detected in all age groups by
detection of HEV RNA in 13.3% serum samples and 8.1% bile samples[39]. In 2016, the
overall  HEV  seroprevalence  was  shown  to  be  32.94%  (range  8.33%-60.00%)  in
domestic pigs from 11 counties and 31.10% (range 7.70%-50.60%) in wild boars from
six Croatian counties. While no positive HEV RNA samples were detected in domestic
pigs, 11.33% seropositive wild boars were found to be HEV RNA positive indicating
that wild boars may have a key role in HEV epidemiology[41].
Data on genetic characterization of HEV are available only for animal species,
confirming genotype 3 in pigs and wild boars. It is important to note a relatively small
sample size of some tested population groups in humans. Therefore, studies on larger
samples as well  as  species comparison studies on HEV genotypes are needed to
obtain better insight into HEV epidemiology/molecular epidemiology in Croatia.
GREECE
In 1995, autochthonous hepatitis E virus was documented in Greece. Several studies
investigated HEV infection in  various population groups in  different  regions in
Greece. A study conducted among patients with clinical signs of hepatitis showed a
significantly higher anti-HEV IgG seroprevalence among acute non-A, non-B hepatitis
patients  (7.6%)  compared to  healthy  controls  (2.2%).  Acute  HEV infection  (IgM
antibodies) was confirmed in 1.0% of acute non-A, non-B hepatitis patients, while one
patient was HEV RNA positive. None of anti-HEV IgM positive patients reported any
possible risk factors[42].
In the north-western Greece (Epirus and Agrinion region), a very low anti-HEV IgG
prevalence was reported in various populations. In Epirus region, none of different
population groups such as  children,  injecting drug users  or  multiply transfused
patients tested positive for HEV antibodies. Seroprevalence in healthy blood donors
was only 0.23%. In contrast, higher anti-HEV prevalence was found among patients
with chronic viral hepatitis (5.3%) and patients on hemodialysis (HD) (1.34%). Even
higher anti-HEV prevalence was found among HD patients in the Agrinion region
(9.7%). No association between the seroprevalence and duration of hemodialysis,
seropositivity for hepatitis  B or C,  history of  hepatitis,  increased alanine amino-
transferase, renal transplantation, history of transfusion or number of units transfused
was detected[17]. Another study from the Epirius region (Ioannina) analyzed the risk of
blood borne HEV transmission among patients after open-heart surgery who had
received more than three blood units  perioperatively.  Past  HEV infections were
documented in 5.2% of surgical patients and 0% of healthy controls[43].
Another study from northern Greece analyzed the presence of antibodies and HEV
RNA in transfusion dependent thalassaemia patients. The study confirmed no past or
acute HEV infection in this multi-transfused population[44].
The most recent data from northern Greece (Thessaloniki) found that 1.3% of liver
transplant patients were positive for HEV RNA. Phylogenetic analysis showed that
the sequences clustered into the HEV genotype 3 clade. The only patient that tested
RNA positive experienced acute hepatitis flare without progression into chronic form.
The HEV RNA prevalence in the Greek transplant population (1.3%) corresponds
with previously reported data in immunocompromised patients from other European
countries[45].
Study from the  semi-rural  region  of  central  Greece  (Thessalia  region)  on  HD
patients in three different HD units found a total seroprevalence rate of 4.8% (varying
from 1.8%-9.8% according to the unit). The highest anti-HEV prevalence was found in
Karditsa unit (9.8%), which finding the authors assume to have been a result of a local
infection in the past. Risk factors for HEV seropositivity (age, sex, duration of HD,
hepatitis B or C virus infection markers, previously elevated aminotransferase levels
or history of transfusion) were not identified[46].
Data from southern Greece showed even higher seroprevalence rates. In 2014, a
study  among  blood  donors  from  urban  population  of  Athens  demonstrated  a
seroprevalence of 9.43%[47]. Furthermore, a study on HIV patients in Athens indicated
7.3% anti-HEV IgG seroprevalence[48].
A recent study from 11 Blood Services throughout Greece revealed 2.9% and 3.6%
of anti-HEV IgG seroprevalence among blood donors and multi-transfused patients,
respectively. The highest seroprevalence rate (13.3%) had male blood donors from
Heraklion, Crete. The seroprevalence was higher in persons older than 50 years (5.9%)
compared to younger group (1.8%)[49].
There is only one study on HEV infection among animals in Greece. The animals
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tested  included  Norway  rats  (Rattus  norvegicus)  and  Black  rats  (R.  rattus)  from
northern Greece, with the total prevalence of 10% in both species[50].
HEV was reported in a leafy green vegetable supply chain in Greece, showing that
HEV RNA was found in 4.76% and 3.2% samples from the primary production and
point-of-sale phases, respectively[51]. Later, the same authors investigated the presence
of HEV in irrigation water samples used for the leafy green vegetables production
and showed that one out of 20 samples tested positive[52].  The sample which was
found HEV positive was a groundwater sample collected from the depth of 100 m,
indicating well contamination unlikely[51].
Further two studies tested sewage samples from Patras (western Greece) for the
presence of  HEV. HEV RNA was not found in any of  the samples[53,54].  Likewise,
commercial mussels tested at the retail in Greece showed no samples positive for HEV
RNA[55].
In  conclusion,  higher  seroprevalence rates  were detected in  southern parts  of
Greece, the highest so far being in Crete, in contrary to the seroprevalence rates in the
northern  regions.  Moreover,  the  prevalence  of  anti-HEV  in  risk  populations
(transplant, HIV, HD patients) was higher than in healthy blood donors. Phylogenetic
analysis of human HEV isolates in Greece showed that the sequences clustered into
the HEV genotype 3 clade. Further researches are needed, especially in animals and
environmental samples in individual regions in Greece to gain a better insight in local
HEV epidemiology.
KOSOVO
An outbreak of acute hepatitis E occurred among the Kosovar refugees in July 1999,
after the return to their country. Several field surveys were undertaken as well as a
serological study in patients with symptoms of hepatitis to assess the possible risk
factors for HEV infection. A higher incidence of HEV infection was found among
well-water consumers compared to those drinking network waters. An acute HEV
infection (anti-HEV IgM positive) was found in 7.7% of refugees that had been tested.
Only four persons had clinical symptoms, while the others were asymptomatic. There
are no other published data on HEV prevalence/seroprevalence in Kosovo[56].
MONTENEGRO
The first available investigation about HEV infection in Montenegro was published in
2009. Data included hospitalized and out-patients with acute viral hepatitis collected
from 2000 to 2007, showing that 6% of patients had acute hepatitis E. Although a
higher  seropositivity  was  found  in  males  (62.5%)  than  in  females  (37.5%),  the
difference was not statistically significant.  Epidemiological data showed that the
majority  of  patients  had  never  travelled  out  of  the  country,  indicating  an
autochthonous HEV infection in Montenegro. An asymptomatic form of the disease
was serologically confirmed in 7/24 patients, whereas the mild or short course of
subclinical disease in 5/7 patients. No one patient had severe, fulminant or chronic
course of disease[57].
ROMANIA
There are several studies on HEV infection in humans in Romania. The earliest human
studies analyzed anti-HEV IgG prevalence in eastern Romania. The seroprevalence
rate of 5.9% was found in the general population[58] and of 12% among patients with
hepatitis B or C[59].
A study from 2010 analyzed the prevalence rates in low risk population groups in
South and South-Eastern  Romania.  The  seroprevalence  of  anti-HEV IgG among
students (mean age: 22.91 ± 0.56 years) was 12.5%, whereas among doctors and nurses
(mean age: 36.71 ± 8.88 years) was 13.98%[60].
A following study from the North-Eastern Romania among persons undergoing
routine  haematological  tests  with  no  signs  of  hepatitis  showed  anti-HEV  IgG
seroprevalence of  17.1% and 12.82% in 2011 and 2012,  respectively.  In  2011,  the
youngest age group (9-20 years) tested negative, whereas as older age groups (> 20
and > 40 years) had seroprevalence of 28.6% and 12.9%, respectively. In 2012, the
youngest age group (18-45 years) had seroprevalence of 6.25%, whereas the older
groups had the seroprevalence up to 28%. These results indicate that HEV infections
in this region mainly affect middle-aged adults. Moreover, anti-HEV IgG was more
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prevalent in women (15.78%) than in men (10%)[61].
One of the earliest animal studies investigated swine population for the presence of
anti-HEV IgG in farm and backyard pigs. The immunoblot results for the backyard
pigs showed seroprevalence rates of 50%[58,62] and for the farm pigs of 38.94%[62].
A more recent study tested fecal samples from five swine farms (pigs aged between
2 and 4 mo) for HEV RNA, and 6 out of 19 samples tested positive. Phylogenetic
analysis showed that Romanian swine isolates grouped into genotype 3 and were
closely related to the swine and human HEV isolates identified in other European
countries[61]. In 2015 and 2016, serological studies investigated HEV prevalence in wild
boars  from eastern Romania.  The seroprevalence rates  were 9.61% (5/52)[63]  and
10.29% (7/68), respectively[64]. A recent study on molecular detection of HEV in liver
and spleen samples from wild boars aged > 1 year from eastern Romania showed an
overall prevalence of 18%. All isolates belonged to the genotype 3 subtypes 3a and
3h[65].
Studies in humans are scarce and new data are needed to define the seroprevalence
of HEV infection. Studies conducted in animal species show high seroprevalence
rates.  Phylogenetic  analyses  show that  Romanian  swine  and  wild  boar  isolates
grouped into genotype 3.
SERBIA
There is only one published study on the HEV seroprevalence in humans in Serbia.
The study was conducted among volunteer blood donors aged 19 to 65 years (average
age  39.3  years),  of  whom  15%  tested  positive  for  anti-HEV  IgG.  No  significant
difference in anti-HEV IgG seropositivity was found between men and women (14.6%
and 16.7%, respectively). HEV seroprevalence increased with age, as higher rates were
recorded in subjects older than 51 years (21.5%) when compared with younger age
groups (< 50 years or < 30 years)[66].
Several studies on HEV prevalence were conducted in Serbia in different animal
species. The first study on HEV in swine population in 2007, tested pooled swine stool
and tissue samples (spleen, mesenteric lymph node and liver). Thirty percent of stool
and 45% of tissue samples tested HEV positive. HEV RNA was detected in four out of
five pig farms examined. Simultaneously, all samples from backyard pigs and wild
boars were negative[67]. Further studies also confirmed the high prevalence of HEV
among pigs in Serbia. The first HEV serology testing in pigs was done on 315 serum
samples collected from 3-4 mo old backyard pigs in 63 herds from 28 towns and
villages  of  four  different  districts  in  northern  Serbia  (Vojvodina  province),
demonstrating seroprevalence rate of 34.6%. The prevalence of anti-HEV antibodies
varied widely  between municipalities  (range 16.7%-75.0%)  and herds  (range (0-
100%)[68].
Furthermore, a study in 2010 analyzed liver tissue samples from 50 dead farm pigs
aged 7  to  15  wk which  died  on  pig  farms  from different  regions  in  Serbia,  and
detected HEV RNA in 13 of samples (26%)[69]. In 2013, a study on 55 serum samples
and meat juice samples collected from three slaughterhouses were analyzed for the
presence of anti-HEV IgG antibodies. The mean seroprevalence in the pig serum and
meat juice samples was 54.54% and 20%, respectively[70]. In addition, stool, liver, bile
and meat samples from 145 animals (95 fatteners and 50 eight weeks piglets) collected
on during slaughter were tested for HEV RNA. Among fatteners,  HEV has been
detected in 7.37% of the stool samples. In piglets, HEV RNA prevalence was high and
detected  in  54%,  26%,  16%  and  10%  samples  of  stool,  bile,  liver  and  meat,
respectively[71]. The presence of HEV IgG and HEV RNA was examined in 201 blood
and 298 liver samples from wild boars culled during hunting season from January
2010 until  February 2011.  The samples  were  collected from 27  hunting grounds
located on the territory of 7 counties of the country. The overall seroprevalence rate
was 34.33%. HEV RNA prevalence was 9.40% with marked regional differences. A
high proportion of  adult  wild sow and wild boars were found positive for  HEV
RNA[72].
In addition to animal studies, there are few data regarding the environment re-
porting the contamination of vegetable supply chain in Serbia. Namely, HEV RNA
was found in 4.76 % and 3.2% of samples of leafy green vegetable from the primary
production and point-of-sale phases, respectively[51]. Another report also documented
the presence of HEV RNA in frozen raspberries (2.6%)[15]. Lately, HEV RNA has also
been detected in surface waters in northern Serbia (Vojvodina Province) where 16.67%
of samples tested positive for HEV RNA, during summer sampling occasion, whereas
none of the tested urban sewage systems tested positive[73].
In Serbia, different population groups should be studied in future in order to reflect
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local epidemiology, modes of transmission and risk factors for HEV infection. Animal
and environmental studies on larger samples as well as studies on HEV genotyping
are needed to obtain better insight into HEV epidemiology.
SLOVENIA
Human studies on HEV infection in Slovenia are scarce. Steyer et al[74] tested 10 serum
samples of patients with the diagnosis of acute/recent hepatitis E based on detection
of HEV IgM antibodies, and three samples tested HEV RNA positive. One sample was
typed as genotype 3, clustered in the lineage "e" and the second was genotype 1 strain.
Slovenian human HEV strains were not related to porcine HEV strains identified in
this study[74].
There are several studies in different animal species in Slovenia. In 2011[74], 20.3%
stool samples of domestic pigs were positive for HEV RNA, of which 5.3%, 28.6% and
26.9% were from suckling, weanling and fattening pigs, respectively. All HEV strains
were analyzed at 5’ ORF1 and 5’ ORF2 regions and both genome regions confirmed
that Slovenian HEV strains represent a distinct genotype 3 lineage. All but one HEV
strains detected in pigs in Slovenia represent a monophyletic branch in phylogenetic
trees, with a high degree of sequence identity. One human HEV strain belonged to
genotype 1 and two to genotype 3 but did not match the new genotype 3 lineage
detected in Slovenian pig herds.
HEV RNA was tested in Norway rat and Black rats from one site close to Ljubljana
and none of the rats tested HEV-RNA positive[50]. The HEV presence in the wild boar
population in Slovenia was first documented in 2016, showing HEV antibodies in
30.2% of animals tested, whereas HEV RNA was detected in only one sample (1/
288)[75].
Recently,  the  possibility  of  HEV  entering  into  the  food  supply  chain  was
investigated in a large study analyzing pigs entering a slaughterhouse. The study
covered three different age groups and three different samples (feces, bile and liver),
showing  the  overall  HEV  RNA  (sample)  prevalence  of  5.4%,  4.9%  and  5.3%,
respectively[76]. In the group of three months old pigs, 13.7% of feces, 13.0% of bile and
2.1% of liver samples were HEV RNA positive. The youngest group originating from
Slovenia  (none  imported),  was  proven  to  be  a  group  for  highest  risk  for  HEV
infection. In the group of six months old pigs (imported from Austria), only one liver
and one bile sample out of 400 tested positive. In the category of sows, no positive
samples were found. The same study analyzed swabs collected at three different sites
on the slaughter line (the hooks that were used to hang the liver and the lung, the
containers in which livers were stored and the hooks for hanging carcasses in the
cooling room). Of 62 swab samples, two were positive (a swab from the hook that
carried  liver  and  one  from  the  liver  container).  However,  all  minced  meat  and
bratwurst samples from these studies tested HEV RNA negative[76]. The phylogenetic
analysis revealed that detected strains were clustered into subtypes 3a, 3b, 3c and 3e.
Further  environmental  studies  investigated  surface  water  and  waste  water
treatment plant. Out of 60 surface water samples tested throughout the country, only
two (3.3%) were HEV RNA positive, one of them in the near vicinity of a pig farm.
HEV sequences detected in the surface water belonged to genotype 3[74]. In another
study, the waste water treatment plant samples were collected from the effluent on a
monthly basis from January to December 2012 and tested for HEV RNA. No HEV
RNA was detected during the whole length of the study, neither before nor after the
concentration step[77].
There are several studies in different animal species showing high prevalence of
HEV RNA in Slovenia, with the genotype 3 being the most common. On the other
hand, studies in humans are lacking.
CONCLUSION
In the South-East Europe, anti-HEV seroprevalence as in other parts of Europe varies
greatly, depending on the population studied, geographical area and assays used for
the detection. Studies on HEV RNA detection and phylogenetic characterization in
human samples showed that  human HEV strains from the South-East  European
countries mainly belong to the genotype 3. Detection of the same genotype in animals
as  well  as  in  the  environment  emphasizes  the  need  of  the  multidisciplinary
collaboration ("One Health" approach) in the surveillance and control of this emerging
infection.
Although significant progress in HEV epidemiology has been made in the past
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decade,  many  important  questions  remain[9].  The  origin  of  HEV  is  still  largely
unknown.  Swine  and  wild  boars  were  proven  to  be  the  primary  natural  HEV
reservoir, but recent studies indicate that rabbits may serve as an additional reservoir
of  HEV[78].  Some  hepatitis  E  cases  observed  in  immunocompromised  patients
clustered with rabbit HEV strains confirming their contribution to zoonotic HEV
transmission[79,80]. It is still unclear whether HEV strains present in other animals can
cross the species barrier and infect humans. However, it is likely that the known host
range of HEV has increased and novel strains continue to be identified. Transmission
of HEV-3 from deer to humans has been described, although deer most probably
undergoes spillover infections from wild boars,  rather than being a natural HEV
reservoir[7]. It seems that recently described new HEV-7 has been widely distributed in
dromedary  camels  from  the  Middle  East [ 3 , 8 ],  but  was  also  detected  in  an
immunocompromised transplant patient who regularly consumed camel milk and
meat[4]. While HEV transmission by breast milk was confirmed in humans[81], a recent
study from China indicates that viral RNA of HEV-4 can be excreted by cow milk[82].
Although cattle have been rarely described to be infected with HEV, these findings
implicate possible HEV transmission through milk or milk products. Human contacts
with other animals, especially pet animals should be investigated in future for better
understanding  of  HEV  epidemiology.  Rabbits  are  commonly  farmed  in  many
countries for meat consumption and fur production but also as pet and possible
transmission from pet house rabbits to humans should be considered as another
possible transmission route[83].  Infection of dogs and cats with HEV is confirmed
serologically[84],  but  their  importance  in  HEV  epidemiology  need  to  be  further
investigated.
Although  HEV  infection  is  not  an  economically  important  pig  disease,
development of a vaccine against the zoonotic genotypes 3 and 4 and vaccination of
swine should be considered as a possible public health measure. Such vaccine should
also be useful for high-risk populations such as organ transplant recipients since the
majority of the chronic hepatitis E are caused by the zoonotic HEV-3[9].
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